Contineum Therapeutics, Inc.
- CTNM
- NASDAQ
- Biotechnology
- Neuroinflammation Drugs
- Small Molecule Therapies
$7.08
Today −10.38%Quote Oct 16, 2026, 08:00 PM UTC
−46.40%over the last month
Max drawdown −47.7%From 1-month high −47.7%3 months −47.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$163.5M
Quote Oct 16
Next earnings
Oct 29
Expected, not confirmed
Analyst target
$21.33
+201.3% from here
Floor
—
Data unavailable
Where the price sits
4 analysts
Analyst range, low to high
$17.00$28.00
- Price $7.08
- Resistance $10.72
- Consensus $21.33
Analysts' average target sits about 201% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CTNMPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
51
Founded
2009